Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

CD117-CD15 in acute myeloid leukemia: no role as LAIP in the study of minimal residual disease.

Rossi G, Nomdedéu Guinot JF, Fontana A, Minervini MM, García-Dabrio MC, Cascavilla N.

Eur J Haematol. 2013 Feb;90(2):171-4. doi: 10.1111/ejh.12042. Epub 2013 Jan 7. No abstract available.

PMID:
23167809
[PubMed - indexed for MEDLINE]
2.

Flow cytometric assessment of CD15+CD117+ cells for the detection of minimal residual disease in adult acute myeloid leukaemia.

Nakamura K, Ogata K, An E, Dan K.

Br J Haematol. 2000 Mar;108(4):710-6.

PMID:
10792273
[PubMed - indexed for MEDLINE]
3.

[Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].

Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.

Zhonghua Xue Ye Xue Za Zhi. 2007 Nov;28(11):731-6. Chinese.

PMID:
18457262
[PubMed - indexed for MEDLINE]
4.

CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.

Cascavilla N, Musto P, D'Arena G, Melillo L, Carella AM, Petrilli MP, Sanpaolo G, Carotenuto M.

Haematologica. 1998 May;83(5):392-7.

PMID:
9658721
[PubMed - indexed for MEDLINE]
Free Article
5.

Evaluation of bone marrow specimens with acute myelogenous leukemia for CD34, CD15, CD117, and myeloperoxidase.

Dunphy CH, Polski JM, Evans HL, Gardner LJ.

Arch Pathol Lab Med. 2001 Aug;125(8):1063-9.

PMID:
11473459
[PubMed - indexed for MEDLINE]
6.

Immunophenotype of c-kit cells in normal human bone marrow: implications for the detection of minimal residual disease in AML.

Macedo A, Orfao A, Martínez A, Vidriales MB, Valverde B, López-Berges MC, San Miguel JF.

Br J Haematol. 1995 Feb;89(2):338-41.

PMID:
7532985
[PubMed - indexed for MEDLINE]
7.

[Immunologic characteristics and prognosis of acute myeloid leukemia M1].

Zhao F, Chen Y.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Aug;15(4):687-91. Chinese.

PMID:
17708783
[PubMed - indexed for MEDLINE]
8.

Chromosome 8 pentasomy with partial tandem duplication of 11q23 in a case of de novo acute myeloid leukemia.

Shin SY, Koo SH, Kwon KC, Park JW, Song JH, Ko YH, Jo DY.

Cancer Genet Cytogenet. 2009 Oct;194(1):44-7. doi: 10.1016/j.cancergencyto.2009.05.005.

PMID:
19737653
[PubMed - indexed for MEDLINE]
9.

[Sensitivity and specificity analysis of the lineage related antibodies in acute leukemia immunophenotyping by flow cytometry].

Chen BG, Zhang L, Li BL, Luo WD.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Apr;13(2):329-31. Chinese.

PMID:
15854304
[PubMed - indexed for MEDLINE]
10.

Importance of CD117 in the evaluation of acute leukemias by flow cytometry.

Newell JO, Cessna MH, Greenwood J, Hartung L, Bahler DW.

Cytometry B Clin Cytom. 2003 Mar;52(1):40-3.

PMID:
12599181
[PubMed - indexed for MEDLINE]
Free Article
11.

[Cytology and immunophenotyping of acute promyelocytary leukaemia].

Gouider E, Ben Salah N, Jeddi R, Belakhal F, Meddeb B, Hafsia R.

Arch Inst Pasteur Tunis. 2006;83(1-4):49-52. French.

PMID:
19388597
[PubMed - indexed for MEDLINE]
12.

[Clinical significance of CD117/CD34 co-expression in adult patients with acute leukemia].

Shi H, Zhu F, Xiao AQ, Zhang ZR, Zhang R.

Ai Zheng. 2006 Jun;25(6):762-4. Chinese.

PMID:
16764777
[PubMed - indexed for MEDLINE]
13.

The singular value of CD34 and CD117 expression for minimal residual disease detection in AML.

Bahia Kerbauy DM, Kimura EY, Chauffaille ML, Bordin JO, Kerbauy J, Yamamoto M.

Leuk Res. 2003 Nov;27(11):1069-70. No abstract available.

PMID:
12860002
[PubMed - indexed for MEDLINE]
14.

Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT, FLT3, and JAK2 mutations on clinical outcome.

Marková J, Marková J, Trnková Z, Michková P, Maaloufová J, Starý J, Cetkovský P, Schwarz J.

Leuk Lymphoma. 2009 Sep;50(9):1448-60. doi: 10.1080/10428190903085951.

PMID:
19603346
[PubMed - indexed for MEDLINE]
15.

C-kit receptor tyrosine kinase (CD117) expression and its positive predictive value for the diagnosis of Thai adult acute myeloid leukemia.

Auewarakul CU, Lauhakirti D, Promsuwicha O, Munkhetvit C.

Ann Hematol. 2006 Feb;85(2):108-12. Epub 2005 Dec 1.

PMID:
16320053
[PubMed - indexed for MEDLINE]
16.

Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.

Ferrari A, Bussaglia E, Úbeda J, Facchini L, Aventin A, Sierra J, Nomdedéu JF.

Hematol Oncol. 2012 Sep;30(3):109-14. doi: 10.1002/hon.1011. Epub 2011 Aug 3.

PMID:
21812014
[PubMed - indexed for MEDLINE]
17.

Usefulness of anti-CD117 in the flow cytometric analysis of acute leukemia.

Hans CP, Finn WG, Singleton TP, Schnitzer B, Ross CW.

Am J Clin Pathol. 2002 Feb;117(2):301-5.

PMID:
11863227
[PubMed - indexed for MEDLINE]
Free Article
18.

CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease.

Scolnik MP, Morilla R, de Bracco MM, Catovsky D, Matutes E.

Leuk Res. 2002 Jul;26(7):615-9.

PMID:
12008077
[PubMed - indexed for MEDLINE]
19.

Specificity of CD117 expression in the diagnosis of acute myeloid leukemia.

Muroi K, Amemiya Y, Miura Y.

Leukemia. 1996 Jun;10(6):1048. No abstract available.

PMID:
8667640
[PubMed - indexed for MEDLINE]
20.

[Prognosticating relapse risk based on multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia].

Wan SG, Zhao H, Sun XJ, He JJ, Su L, Xu J.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):557-62. Chinese.

PMID:
19549363
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk